<SEC-DOCUMENT>0000899243-18-004076-index.html : 20180214
<SEC-HEADER>0000899243-18-004076.hdr.sgml : 20180214
<ACCEPTANCE-DATETIME>20180214215236
ACCESSION NUMBER:		0000899243-18-004076
CONFORMED SUBMISSION TYPE:	5
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171231
FILED AS OF DATE:		20180214
DATE AS OF CHANGE:		20180214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TIDMARSH GEORGE F
		CENTRAL INDEX KEY:			0001287235

	FILING VALUES:
		FORM TYPE:		5
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		18615991

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>5
<SEQUENCE>1
<FILENAME>doc5.xml
<DESCRIPTION>FORM 5 SUBMISSION
<TEXT>
Document 1 - file: doc5.html

Document 1 - RAW XML: doc5.xml

</DOCUMENT>
</SEC-DOCUMENT>